The European Union’s medicines regulator on Friday said it has approved new manufacturing sites for coronavirus vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca-Oxford, in a move that could significantly boost Europe’s supply of the shots and speed vaccination efforts across the continent.
